K Wu Selected Research

o-Chlorobenzylidenemalonitrile (Tear Gas, CS)

1/2011

Acute generalized exanthematous pustulosis induced by a topical agent: 2-chlorobenzylidene malonitrile (CS) gas.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

K Wu Research Topics

Disease

29	Neoplasms (Cancer) 01/2022 - 04/2000
11	Stomach Neoplasms (Stomach Cancer) 01/2022 - 02/2001
9	Neoplasm Metastasis (Metastasis) 01/2022 - 10/2001
8	Infections 01/2022 - 09/2000
7	Carcinoma (Carcinomatosis) 10/2020 - 02/2000
6	Carcinogenesis 03/2012 - 04/2000
5	Breast Neoplasms (Breast Cancer) 09/2015 - 03/2000
3	Hemorrhage 01/2022 - 04/2007
3	Adenoma (Adenomas) 01/2016 - 02/2001
3	Colorectal Neoplasms (Colorectal Cancer) 03/2012 - 09/2002
2	Hepatocellular Carcinoma (Hepatoma) 05/2020 - 02/2006
2	Birth Weight (Birth Weights) 01/2019 - 09/2017
2	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2019 - 10/2000
2	Mouth Neoplasms (Oral Cancer) 01/2019 - 02/2016
2	Body Weight (Weight, Body) 03/2017 - 12/2013
2	Hypoxia (Hypoxemia) 01/2016 - 05/2008
2	Renal Cell Carcinoma (Grawitz Tumor) 01/2016 - 04/2013
2	Hypertension (High Blood Pressure) 12/2015 - 07/2014
2	Prostatic Neoplasms (Prostate Cancer) 10/2015 - 04/2014
2	Necrosis 05/2013 - 07/2010
2	Leukemia 04/2013 - 08/2001
2	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 04/2013 - 06/2012
2	Ulcerative Colitis 11/2012 - 02/2010
2	Coronary Disease (Coronary Heart Disease) 04/2009 - 10/2005
2	Stroke (Strokes) 10/2005 - 03/2000
2	Seizures (Absence Seizure) 01/2003 - 01/2001
2	Temporal Lobe Epilepsy 01/2003 - 01/2001
2	Atrophy 06/2002 - 12/2001
1	Wounds and Injuries (Trauma) 01/2022
1	Intestinal Obstruction (Obstruction, Intestinal) 01/2022
1	Hypoalbuminemia 01/2022
1	Anemia 01/2022
1	Pleural Effusion (Pleural Effusions) 01/2022
1	Anastomotic Leak 01/2022
1	Adenocarcinoma 01/2022
1	Gastroparesis 01/2022
1	Hematoma 12/2021
1	Chronic Subdural Hematoma 12/2021
1	Graves Disease (Basedow Disease) 02/2021
1	Esophageal Squamous Cell Carcinoma 04/2020
1	Non-Muscle Invasive Bladder Neoplasms 02/2020
1	Herpes Simplex Encephalitis (Herpes Encephalitis) 11/2019
1	Nasopharyngeal Carcinoma 06/2019
1	Fistula 01/2019
1	Lung Diseases (Lung Disease) 01/2019

Drug/Important Bio-Agent (IBA)

10	Proteins (Proteins, Gene)FDA Link 05/2020 - 02/2000
6	Small Interfering RNA (siRNA)IBA 09/2015 - 01/2005
5	Biomarkers (Surrogate Marker)IBA 09/2015 - 01/2008
5	Biological ProductsIBA 12/2014 - 12/2006
4	Pharmaceutical PreparationsIBA 03/2021 - 09/2002
4	Messenger RNA (mRNA)IBA 04/2016 - 04/2000
4	MicroRNAs (MicroRNA)IBA 09/2015 - 10/2010
3	CytokinesIBA 02/2021 - 09/2015
3	Cadherins (E-Cadherin)IBA 02/2020 - 02/2006
3	ORALIT (ORS)IBA 09/2017 - 01/2008
3	EnzymesIBA 08/2017 - 09/2000
3	Sirolimus (Rapamycin)FDA Link 08/2015 - 07/2011
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 07/2014 - 10/2001
3	alpha-Tocopherol FDA Link 02/2001 - 05/2000
2	Interleukin-6 (Interleukin 6)IBA 02/2021 - 05/2013
2	Interleukin-1 (Interleukin 1)IBA 02/2021 - 06/2002
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 02/2021 - 07/2010
2	Oxygen (Dioxygen)IBA 01/2019 - 12/2004
2	AntigensIBA 08/2017 - 02/2006
2	Insulin (Novolin)FDA Link 01/2016 - 03/2013
2	AndrogensIBA 01/2016 - 10/2015
2	Phosphotransferases (Kinase)IBA 01/2016 - 05/2008
2	RNA (Ribonucleic Acid)IBA 09/2015 - 02/2001
2	Transcription Factors (Transcription Factor)IBA 12/2014 - 05/2008
2	Sorafenib (BAY 43-9006)FDA Link 07/2014 - 04/2013
2	Infliximab (Remicade)FDA Link 11/2012 - 02/2010
2	N- (3- aminopropyl)- N- (1- (5- benzyl- 3- methyl- 4- oxo- (1,2)thiazolo(5,4- d)pyrimidin- 6- yl)- 2- methylpropyl)- 4- methylbenzamideIBA 06/2012 - 01/2012
2	Fibrinogen (Factor I)FDA Link 04/2009 - 10/2005
2	IodineIBA 01/2008 - 05/2007
2	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 06/2007 - 12/2006
2	ArsenicIBA 03/2007 - 06/2001
2	Laminin (Merosin)IBA 01/2005 - 02/2001
2	Kainic Acid (Kainate)IBA 01/2003 - 01/2001
2	Urethane (Ethyl Carbamate)IBA 01/2003 - 01/2001
2	Monoclonal AntibodiesIBA 09/2002 - 11/2001
1	Atorvastatin (Lipitor)FDA Link 12/2021
1	Immune Checkpoint InhibitorsIBA 10/2020
1	PlatinumIBA 10/2020
1	rho GTP-Binding Proteins (rho GTP-Binding Protein)IBA 05/2020
1	Long Noncoding RNAIBA 08/2019

Therapy/Procedure

12	Therapeutics 11/2019 - 11/2001
3	Aftercare (After-Treatment) 01/2017 - 07/2001
3	Transplantation 12/2016 - 01/2008
2	Radiotherapy 06/2019 - 10/2000
2	Lasers (Laser) 01/2016 - 08/2014
1	Gastrectomy 01/2022
1	Conservative Treatment 01/2022
1	Perioperative Period 01/2022
1	Hyperthermic Intraperitoneal Chemotherapy 01/2022
1	Immunotherapy 10/2020
1	Laparotomy 04/2020
1	Neoadjuvant Therapy 04/2020
1	Anesthesia 04/2020
1	Thoracotomy 04/2020
1	Minimally Invasive Surgical Procedures 04/2020